Biofrontera (BFRI) Receivables - Net (2020 - 2025)

Biofrontera's Receivables - Net history runs 6 years deep, the most recent figure standing at $7.3 million for Q4 2025.

• On a quarterly basis, Receivables - Net rose 37.18% year-over-year to $7.3 million in Q4 2025; TTM through Dec 2025 was $7.3 million, a 37.18% increase from a year earlier, with the FY2025 full-year figure at $7.3 million, up 37.18% from the prior year.
• Receivables - Net advanced to $7.3 million in Q4 2025 per BFRI's latest filing, from $3.0 million in the prior quarter.
• Across five years, Receivables - Net topped out at $7.3 million in Q4 2025 and bottomed at $1.6 million in Q3 2022.
• The 5-year median for Receivables - Net is $3.8 million (2021), against an average of $3.8 million.
• Across the five-year window, Receivables - Net jumped 142.83% in 2023 and tumbled 38.55% in 2025, its largest moves.
• Year by year, Receivables - Net stood at $3.8 million in 2021, then declined by 0.95% to $3.7 million in 2022, then surged by 37.73% to $5.2 million in 2023, then grew by 2.96% to $5.3 million in 2024, then jumped by 37.18% to $7.3 million in 2025.
• Per Business Quant, the three latest BFRI Receivables - Net figures stand at $7.3 million (Q4 2025), $3.0 million (Q3 2025), and $4.0 million (Q2 2025).